` PRFX (PainReform Ltd) vs S&P 500 Comparison - Alpha Spread

PRFX
vs
S&P 500

Over the past 12 months, PRFX has underperformed S&P 500, delivering a return of -86% compared to S&P 500's +19% growth.

Stocks Performance
PRFX vs S&P 500

Loading...
PRFX
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
PRFX vs S&P 500

Loading...
PRFX
S&P 500
Difference
www.alphaspread.com

Performance By Year
PRFX vs S&P 500

Loading...
PRFX
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
PainReform Ltd vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

PainReform Ltd
Glance View

Market Cap
2.9m USD
Industry
Pharmaceuticals

PainReform Ltd. operates as a pharmaceutical company. The Company’s main activity is to develop reformulation of established pain therapeutics. PainReform Ltd provides technology, which is dedicated to prolong and enhance efficacy, minimize adverse effects and increase patients convenience as well as faster return of motor function.

PRFX Intrinsic Value
$0.727
Overvaluation 25%
Intrinsic Value
Price $0.968
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett